Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulsatile versus continuous intravenous oxytocin for induction or augmentation of labour
ACTRN12619000588190Phase 4Terminated
- Sponsor
- Darren Lowen
- Start
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oxytocin (2 arms), sponsored by Darren Lowen. Primary endpoint: Emergency caesarean section incidence. Started Jul 2019; status: terminated.
02
Drugs
oxytocin
Beyond the preview
Go deeper on ACTRN12619000588190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000588190.